Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.
Yingying XuYakun WangJifang GongXiaotian ZhangZhi PengXinan ShengChenyu MaoQingxia FanYuxian BaiYi BaDa JiangFen YangChangsong QiJian LiXicheng WangJun ZhouMing LuYanshuo CaoJiajia YuanDan LiuZhenghang WangJianmin FangLin ShenPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)
NCT02881190.